Breaking News Bar

Business News and Information

After big buyout, team looks to lead hepatitis B, NASH drug maker to $100M IPO

Much of the team that led Alios — without a "g" — to aa $1.8 billion acquisition now is back with Aligos.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear